These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27139060)

  • 1. Association Between Availability of a Price Transparency Tool and Outpatient Spending.
    Desai S; Hatfield LA; Hicks AL; Chernew ME; Mehrotra A
    JAMA; 2016 May; 315(17):1874-81. PubMed ID: 27139060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance.
    Gourevitch RA; Chien AT; Bambury EA; Shah NT; Riedl C; Rosenthal MB; Sinaiko AD
    JAMA Netw Open; 2021 Aug; 4(8):e2121410. PubMed ID: 34406401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who Uses a Price Transparency Tool? Implications for Increasing Consumer Engagement.
    Gourevitch RA; Desai S; Hicks AL; Hatfield LA; Chernew ME; Mehrotra A
    Inquiry; 2017 Jan; 54():46958017709104. PubMed ID: 28523946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees.
    Desai S; Hatfield LA; Hicks AL; Sinaiko AD; Chernew ME; Cowling D; Gautam S; Wu SJ; Mehrotra A
    Health Aff (Millwood); 2017 Aug; 36(8):1401-1407. PubMed ID: 28784732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
    Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
    JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between availability of health service prices and payments for these services.
    Whaley C; Schneider Chafen J; Pinkard S; Kellerman G; Bravata D; Kocher R; Sood N
    JAMA; 2014 Oct 22-29; 312(16):1670-6. PubMed ID: 25335149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Price Transparency: Not a Panacea for High Health Care Costs.
    Volpp KG
    JAMA; 2016 May; 315(17):1842-3. PubMed ID: 27139056
    [No Abstract]   [Full Text] [Related]  

  • 8. A health plan work in progress: hospital-physician price and quality transparency.
    Tynan A; Liebhaber A; Ginsburg PB
    Res Brief; 2008 Aug; (7):1-8. PubMed ID: 18831095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Reference Pricing for Diagnostic Laboratory Testing With Changes in Patient Choices, Prices, and Total Spending for Diagnostic Tests.
    Robinson JC; Whaley C; Brown TT
    JAMA Intern Med; 2016 Sep; 176(9):1353-9. PubMed ID: 27454826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of employment-based health plans.
    Fronstin P
    EBRI Issue Brief; 1998 Sep; (201):1-21. PubMed ID: 10345788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and Cost of an Employer-Sponsored Comprehensive Primary Care Delivery Model.
    Basu S; Zhang T; Gilmore A; Datta E; Kim EY
    JAMA Netw Open; 2020 Apr; 3(4):e203803. PubMed ID: 32352529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-Pocket Spending for Hospitalizations Among Nonelderly Adults.
    Adrion ER; Ryan AM; Seltzer AC; Chen LM; Ayanian JZ; Nallamothu BK
    JAMA Intern Med; 2016 Sep; 176(9):1325-32. PubMed ID: 27367932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference Pricing, Consumer Cost-Sharing, and Insurer Spending for Advanced Imaging Tests.
    Robinson JC; Whaley C; Brown TT
    Med Care; 2016 Dec; 54(12):1050-1055. PubMed ID: 27479594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Price Transparency: Still Opaque With Opportunities for Improvement.
    Faherty LJ; Wong CA; Feingold J; Li J; Town R; Fieldston E; Werner RM
    Hosp Pediatr; 2017 Oct; 7(10):565-571. PubMed ID: 28874404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
    Joynt KE; Gawande AA; Orav EJ; Jha AK
    JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will choice-based reform work for Medicare? Evidence from the Federal Employees Health Benefits Program.
    Florence CS; Atherly A; Thorpe KE
    Health Serv Res; 2006 Oct; 41(5):1741-61. PubMed ID: 16987300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral health insurance parity for federal employees.
    Goldman HH; Frank RG; Burnam MA; Huskamp HA; Ridgely MS; Normand SL; Young AS; Barry CL; Azzone V; Busch AB; Azrin ST; Moran G; Lichtenstein C; Blasinsky M
    N Engl J Med; 2006 Mar; 354(13):1378-86. PubMed ID: 16571881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of price transparency on consumers and providers: A scoping review.
    Zhang A; Prang KH; Devlin N; Scott A; Kelaher M
    Health Policy; 2020 Aug; 124(8):819-825. PubMed ID: 32576391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.